Skip to main content
. 2015 Mar 19;4(7):e1014760. doi: 10.1080/2162402X.2015.1014760

Figure 6.

Figure 6.

In vivo expression and organization of desmin as a marker of myogenic differentiation in A204 RMS. (A) Histologic slides from tumors (n = 3/cohort) of all cohorts (FcIL-7, NHS-IL12/FcIL-7, or NHS-IL12/IL-2MAB602 treated) were stained for desmin (scale bars: 200 µm) and analyzed by a pathologist (B) in a blinded manner. LT: long-term treatment; ST: short-term treatment.